Health
Antibodies from COVID-19 infection protect patients for six months – Drug Target Review
A study in healthcare workers has shown that antibodies from COVID-19 infection protect individuals for at least six months.
Posted: 24 November 2020 | Victoria Rees (Drug Target Review) | No comments yet
A study in healthcare workers has shown that antibodies from COVID-19 infection protect individuals from reinfection for at least six months.
A new study suggests that individuals who have previously had COVID-19 are highly unlikely to contract the illness again for at least six months following their first infection. The study was conducted as part of a collaboration between the University of Oxford and Oxford University…
Continue Reading